Elevated Levels of IL-6, INF-γ, And Tnf-α In Mice in Response to Cotton Dust are Modulated by Anti-Tnf-α Antiserum

References

• Beutler B, Cerami A. The biology of cachectin/TNF: a primary mediator of host response. Annu Rev Immunol. 1989; 7: 625–655
   PubMed Web of Science ®Google Scholar
• Fukushima R, Alexander JW, Gianotti L, Ogle C. The lung as a major source of systemic TNF. Crit Care Med. 1994; 22: 114–128
   PubMedGoogle Scholar
• Kohase M, May LT, Tamm I, Vilcek J, Sehgal PB. A cytokine network in human diploid fibroblast: interaction of beta interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1. Mol Cell Biol. 1988; 7: 273–280
   Web of Science ®Google Scholar
• Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines, 2: interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol. 1991; 138: 1097–1101
   PubMed Web of Science ®Google Scholar
• Sheron N, Lau JN, Hoffmann J, Williams R, Alexander GJM. Dose dependent increase in plasma interleukin-6 after recombinant tumor necrosis factor infusion in humans. Clin Exp Immunol. 1990; 82: 427–428
   PubMed Web of Science ®Google Scholar
• McIntosh JK, Jablons DM, Mule JJ, et al. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. J Immunol. 1989; 143: 162–167
   PubMed Web of Science ®Google Scholar
• Van Deventer SJH, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76: 2520–2626
   PubMed Web of Science ®Google Scholar
• Heremans H, Van Damme J, Dillen C, Dijkmans R, Billiau A. Interferon-γ, a mediator of lethal lipopolysaccharide-induced Shwartzman-like shock reactions in mice. J Exp Med. 1990; 171: 1853–1869
   PubMed Web of Science ®Google Scholar
• Billiau A, Matthys P, Martens E, Heremans H. Effects of anti-interferon-γ and anti-interleukin-6 antibodies in disease models in mice: antibodies as carriers of cytokines. J Interferon Res. 1994; 14: 277–279
   PubMedGoogle Scholar
• Martens E, Dillen C, Put W, Heremans M, Van Damme J, Billiau A. Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes. Eur J Immunol. 1993; 23: 2026–2029
   Google Scholar
• Talmadge JE, Bowersox O, Tribble H, Lee SH, Shepard HM, Liggit D. Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitors. Am J Pathol. 1987; 128: 410–425
   PubMed Web of Science ®Google Scholar
• Doherty GM, Lange JR, Langstein HN, Alexander HR, Buresh CM, Norton JA. Evidence for INF-7 as a mediator of the lethality of endotoxin and tumor necrosis factor-α. J Immunol. 1992; 149: 1666–1670
   PubMed Web of Science ®Google Scholar
• Ryan LK, Karol MH. Release of tumor necrosis factor in guinea pigs upon acute inhalation of cotton dust. Am J Respir Cell Mol Biol. 1991; 5: 93–98
   PubMed Web of Science ®Google Scholar
• Griffiths-Johnson DA, Ryan L, Karol MH. Development of an animal model for organic dust toxic syndrome. Inhal Toxicol. 1991; 3: 405–417
   Google Scholar
• Ryan LK, Jin R, Boggs SS, Karol MH, Day BW. Mouse model for assessing endotoxin involvement in the lung inflammation and cytokine production resulting from inhaled organic dust. Inhalation Toxicology 1994; 6: 485–499
   Web of Science ®Google Scholar
• Shvedova AA, Kramarik JA, Keohavong P, Chumakov KM, Karol MH. Use of anti-TNF-a antiserum to investigate toxic alveolitis arising from cotton dust exposures. Exp Lung Res. 1994; 20: 297–315
   PubMed Web of Science ®Google Scholar
• Ruppel-Kerr R, Lemp JA, Karol MH. Antibody to recombinant mouse tumor necrosis factor (TNF) neutralizes guinea pig TNF. J Immunol Methods. 1992; 154: 179–184
   PubMed Web of Science ®Google Scholar
• Laviolette M, Carreau M, Coulombe R. Bronchoalveolar lavage cell differential on microscope glass cover: a simple and accurate technique. Am Rev Respir Dis. 1988; 138: 451–457
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin ER, Kagan VE, Karol MH. Increased lipid peroxidation and decreased antioxidants in lungs of guinea pigs following an allergic pulmonary response. Toxicol Appl Pharmacol. 1995; 132: 72–81
   PubMed Web of Science ®Google Scholar
• Starnes HF, Jr, Pearce MK, Tewari A, Yim JH, Zou J-C, Abrams JS. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J Immunol. 1990; 145: 4185–4191
   PubMed Web of Science ®Google Scholar
• Shieh J-H, Peterson RHF, Moore MAS. Bacterial endotoxin regulation of cytokine receptors on murine bone marrow cells: in vivo and in vitro study. J Immunol. 1994; 152: 859–866
   PubMed Web of Science ®Google Scholar
• Shalaby MR, Waage A, Aarden L, Espevik T. Endotoxin, tumor necrosis factor-α and interleu-kin-1 induce interleukin-6 in vivo. Clin Immunol Immunopathol. 1989; 53: 488–498
   PubMedGoogle Scholar
• Zanetti G, Heumann D, Gérain J, et al. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice: comparative protective efficacy of antibodies to tumor necrosis factor-a and to lipopolysaccharide. J Immunol. 1992; 148: 1890–1897
   PubMed Web of Science ®Google Scholar
• Kuipers B, van der Poll T, Levi M, et al. Platelet-activating factor antagonist TCV-309 attenuates the induction of cytokines network in experimental endotoxemia in chimpanzees. J Immunol. 1994; 152: 2438–2446
   PubMed Web of Science ®Google Scholar
• Lindsey DC, Emerson TE, Jr, Thompson TE, et al. Characterization of an endotoxemic baboon model of metabolic and organ dysfunction. Circ Shock. 1991; 34: 298–310
   PubMedGoogle Scholar
• Fischer E, Marano MA, Van Zee KJ, et al. Interleukin-1 receptor blockade improves survival and hemodynamic performance in Escherichia coli septic shock, but fails to alter host responses to sublethal endotoxemia. J Clin Invest 1992; 898: 1551–1557
   Google Scholar
• Mackensen A, Galanos C, Engelhardt R. Treatment of cancer patients with endotoxin induces release of endogenous cytokines. Pathobiology. 1990; 59: 264–267
   Web of Science ®Google Scholar
• Waage A, Brandtzaeg P, Halstensen A, Keirulf P, Espevik T. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med. 1989; 169: 333–338
   PubMed Web of Science ®Google Scholar
• Waage A, Steinshamn S. Cytokine mediators of septic infections in the normal and granulocytopenic host. Eur J Haematol. 1993; 50: 243–249
   PubMed Web of Science ®Google Scholar
• Richardson RP, Rhyne CD, Fong Y, et al. Peripheral blood leukocyte kinetics following in vivo lipopolysaccharide (LSP) administration to normal human subjects: influence of elicited hormones and cytokines. Ann Surg. 1989; 210: 239–245
   PubMed Web of Science ®Google Scholar
• Barber AE, Coyle SM, Marano MA, et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol. 1993; 150: 1999–2006
   PubMed Web of Science ®Google Scholar
• Fong Y, Moldawer LL, Marano M, et al. Endotoxemia elicits increased circulating beta 2-IFN/ IL-6 in man. J Immunol. 1989; 142: 2321–2324
   PubMed Web of Science ®Google Scholar
• Michel O, Duchateau J, Sergysels R. Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects. J Appl Physiol. 1989; 66: 1059–1064
   PubMed Web of Science ®Google Scholar
• Michel O, Ginanni R, Le Bon B, Content J, Duchateau J, Sergysels R. Inflammatory response to acute inhalation of endotoxin in asthmatic patients. Am Rev Respir Dis. 1992; 146: 352–357
   PubMed Web of Science ®Google Scholar
• Engelberts I, von Asmuth EJ, van der Linen CJ, Buurman WA. The interrelation between TNF, IL-6, and PAF secretion induced by LPS in an in vivo and in vitro murine model. Lymphokine Cytokine Res. 1991; 10: 127–131
   PubMedGoogle Scholar
• Fong Y, Tracey KJ, Moldawer LL, et al. Antibodies to cachectin tumor/necrosis factor reduce interleukin-1β and interleukin-6 appearance during lethal bacteremia. J Exp Med. 1989; 170: 1627–1633
   PubMed Web of Science ®Google Scholar
• Hinshaw LB, Emerson TE, Jr, Taylor FB, Jr, et al. Lethal staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J Trauma. 1992; 33: 568–573
   PubMed Web of Science ®Google Scholar
• Schultz RM, Kleinschmidt WJ. Functional identity between murine 7 interferon and macrophage activating factor. Nature 1983; 305: 239–240
   PubMed Web of Science ®Google Scholar
• Tsujimoto M, Yip YK, Vilcek J. Interferon-γ enhances expression of cellular receptors for tumor necrosis factor. J Immunol. 1986; 136: 2441–2444
   PubMed Web of Science ®Google Scholar
• Beckerman KP, Rogers HW, Corbett JA, Schreiber RD, McDaniel ML, Unanue ER. Release of nitric oxide during the T cell-independent pathway of macrophage activation. J Immunol. 1993; 150: 888–895
   PubMed Web of Science ®Google Scholar